AE

Research News

Aseptic Enclosures – Research News

Don’t Stop Production for Cleanroom Renovation

When renovating a cleanroom, or creating one from non-cleanroom space, understanding the details — of the site, building, planned research, and equipment — is essential. Cleanrooms are like race cars. When properly designed and built, they are highly efficient performance machines. When poorly designed and built, they operate poorly and are unreliable. The cost of cleanroom varies […]

Don’t Stop Production for Cleanroom Renovation Read More »

When renovating a cleanroom, or creating one from non-cleanroom space, understanding the details — of the site, building, planned research, and equipment — is essential. Cleanrooms are like race cars. When properly designed and built, they are highly efficient performance machines. When poorly designed and built, they operate poorly and are unreliable. The cost of cleanroom varies

Pharma D Solutions voluntarily recalls all sterile compounded drugs

All sterile compounded drug products from Pharma D Solutions are being voluntarily recalled due to a potential contamination risk at the pharmacy, according to a company press release. The drugs affected by the recall include any compounded at the pharmacy within the past 12 months, which were distributed nationwide and directly to customers and medical

Pharma D Solutions voluntarily recalls all sterile compounded drugs Read More »

All sterile compounded drug products from Pharma D Solutions are being voluntarily recalled due to a potential contamination risk at the pharmacy, according to a company press release. The drugs affected by the recall include any compounded at the pharmacy within the past 12 months, which were distributed nationwide and directly to customers and medical

503B Audits and Services

        Under the FCDA Act, outsourcing facilities register with, and are regulated and inspected by FDA as 503B outsourcing facilities. An outsourcing facility will be able to qualify for exemptions from the FDA approval requirements and the requirement to label products with adequate directions for use, but not the exemption from CGMP

503B Audits and Services Read More »

        Under the FCDA Act, outsourcing facilities register with, and are regulated and inspected by FDA as 503B outsourcing facilities. An outsourcing facility will be able to qualify for exemptions from the FDA approval requirements and the requirement to label products with adequate directions for use, but not the exemption from CGMP

USP Compounding General Chapters Now Available for Public Comment

USP Compounding General Chapters are now available for public comment. The USP team has scheduled an Open Microphone session for September 5, 2018. During the Open Microphone session, USP will highlight changes in the proposed revised standard and answer stakeholder questions about the approach and methodology of the revision.   To register please follow this link

USP Compounding General Chapters Now Available for Public Comment Read More »

USP Compounding General Chapters are now available for public comment. The USP team has scheduled an Open Microphone session for September 5, 2018. During the Open Microphone session, USP will highlight changes in the proposed revised standard and answer stakeholder questions about the approach and methodology of the revision.   To register please follow this link

Choosing Engineering Controls Under USP 800

The risks to health care workers handling hazardous drugs (HDs) under non-USP compliant conditions are often underappreciated. The development of the USP 800 chapter provides a framework of 18 sections that guide HD compounding practices to ensure the safety not only of patients, but also of the health care workers who prepare and administer these

Choosing Engineering Controls Under USP 800 Read More »

The risks to health care workers handling hazardous drugs (HDs) under non-USP compliant conditions are often underappreciated. The development of the USP 800 chapter provides a framework of 18 sections that guide HD compounding practices to ensure the safety not only of patients, but also of the health care workers who prepare and administer these

XLTC800 for Tablet Pressing

  Here in Aseptic Enclosures we have encountered a project where we were called upon to come up with a solution that will provide ISO class 5 conditions for compounding tablets. The issues we had successfully overcome were: increasing safety of the pharmacist, assuring sterility of the product, limit particulate emissions and avoid risks for

XLTC800 for Tablet Pressing Read More »

  Here in Aseptic Enclosures we have encountered a project where we were called upon to come up with a solution that will provide ISO class 5 conditions for compounding tablets. The issues we had successfully overcome were: increasing safety of the pharmacist, assuring sterility of the product, limit particulate emissions and avoid risks for

Pharmacy Planning and Design Projects

  When it comes to clean room design, fabrication, installation, pricing, and customer service, we do clean rooms right. Whatever you’re looking for in a clean room, from economical soft wall installations to the top of the line hard wall construction for permanent use, our clean room value is second to none. We sell our

Pharmacy Planning and Design Projects Read More »

  When it comes to clean room design, fabrication, installation, pricing, and customer service, we do clean rooms right. Whatever you’re looking for in a clean room, from economical soft wall installations to the top of the line hard wall construction for permanent use, our clean room value is second to none. We sell our

Media Fill by Aseptic Enclosures

A media fill is the performance of an aseptic manufacturing procedure using a sterile microbiological growth medium, in place of the drug solution, to test whether the aseptic procedures are adequate to prevent contamination during actual drug production.   In aseptic processing, it is intended that a product and its containment system (separately sterilized) are brought together

Media Fill by Aseptic Enclosures Read More »

A media fill is the performance of an aseptic manufacturing procedure using a sterile microbiological growth medium, in place of the drug solution, to test whether the aseptic procedures are adequate to prevent contamination during actual drug production.   In aseptic processing, it is intended that a product and its containment system (separately sterilized) are brought together

Compounding Aseptic Containment Isolator from Aseptic Enclosures

We would like to start the New Year by introducing our Compounding Aseptic Containment Isolator. These close isolators provide a better physical barrier to protect the health of laboratory workers, maintain the sterility of experimental materials, and prevent the contamination of the environment. Closed containment cabinets are safer to use in research laboratories to provide a clean

Compounding Aseptic Containment Isolator from Aseptic Enclosures Read More »

We would like to start the New Year by introducing our Compounding Aseptic Containment Isolator. These close isolators provide a better physical barrier to protect the health of laboratory workers, maintain the sterility of experimental materials, and prevent the contamination of the environment. Closed containment cabinets are safer to use in research laboratories to provide a clean

Cleaning Compounding Aseptic Isolators

  Using the right techniques and procedures can make cleaning sterile compounding areas a matter of routine. Since the June 1, 2008 revision of USP general chapter 797, pharmaceutical compounding personnel have been held responsible for the cleanliness of their sterile compounding areas, including biosafety cabinets (BSCs), compounding aseptic isolators (CAIs), compounding aseptic containment isolators

Cleaning Compounding Aseptic Isolators Read More »

  Using the right techniques and procedures can make cleaning sterile compounding areas a matter of routine. Since the June 1, 2008 revision of USP general chapter 797, pharmaceutical compounding personnel have been held responsible for the cleanliness of their sterile compounding areas, including biosafety cabinets (BSCs), compounding aseptic isolators (CAIs), compounding aseptic containment isolators